Trump Announces Deal to Lower Costs of Obesity Drugs Wegovy and Zepbound

Deal to Lower Obesity Drug Costs

• 🤝 President Trump announced a deal with Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their obesity treatments, Zepbound and Wegovy.
• 💰 The high cost of these drugs, often around $500 per month or more, has made access difficult for many patients.

Expanded Coverage and Pricing

• Medicare patients, primarily those aged 65 and over, will see expanded coverage for these obesity drugs starting next year.
• 📉 The administration also stated that some lower prices will be phased in for patients who do not have existing coverage.
• ⚠️ It remains unclear how significantly consumers will feel the impact of the price reduction.

How Obesity Drugs Work

• 🎯 These drugs function by targeting hormones in the gut and brain that regulate appetite and satiety.
• 📊 Clinical trials have shown these medications can help individuals lose between 15% and 22% of their body weight.